Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?

Wojciech Łężak; Łukasz Mokros; Jakub M. Kaźmierski; Dominik Strzelecki; Hanna Jerczyńska; Edward Kowalczyk; Tadeusz Pietras

doi:10.5114/ppn.2020.103632

Streszczenie

4/2020 vol. 29

Artykuł oryginalny

Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?

Wojciech Łężak ¹

,

Łukasz Mokros ²

,

Jakub M. Kaźmierski ³

,

Dominik Strzelecki ⁴

,

Hanna Jerczyńska ⁵

,

Edward Kowalczyk ¹

,

Tadeusz Pietras ^{2, 6}

Department of Pharmacology and Toxicology, Medical University of Lodz, Poland
Department of Clinical Pharmacology of the 1st Chair of Internal Diseases, Medical University of Lodz, Poland
Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Poland
Department of Affective and Psychotic Disorders, Medical University of Lodz, Poland
Central Scientific Laboratory (CoreLab), Medical University of Lodz, Poland
Department of Neuroses, Personality Disorders and Eating Disorders, Institute of Psychiatry and Neurology, Warsaw, Poland

Adv Psychiatry Neurol 2020; 29 (4): 205-214

DOI: https://doi.org/10.5114/ppn.2020.103632

Data publikacji online: 2021/01/30

Pełna treść artykułu

AMA

Łężak W, Mokros Ł, Kaźmierski J, et al. Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii. 2020;29(4):205-214. doi:10.5114/ppn.2020.103632.

APA

Łężak, W., Mokros, Ł., Kaźmierski, J., Strzelecki, D., Jerczyńska, H., & Kowalczyk, E. et al. (2020). Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, 29(4), 205-214. https://doi.org/10.5114/ppn.2020.103632

Chicago

Łężak, Wojciech, Łukasz Mokros, Jakub M. Kaźmierski, Dominik Strzelecki, Hanna Jerczyńska, Edward Kowalczyk, and Tadeusz Pietras. 2020. "Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?". Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii 29 (4): 205-214. doi:10.5114/ppn.2020.103632.

Harvard

Łężak, W., Mokros, Ł., Kaźmierski, J., Strzelecki, D., Jerczyńska, H., Kowalczyk, E., and Pietras, T. (2020). Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, 29(4), pp.205-214. https://doi.org/10.5114/ppn.2020.103632

MLA

Łężak, Wojciech et al. "Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?." Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii, vol. 29, no. 4, 2020, pp. 205-214. doi:10.5114/ppn.2020.103632.

Vancouver

Łężak W, Mokros Ł, Kaźmierski J, Strzelecki D, Jerczyńska H, Kowalczyk E et al. Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?. Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii. 2020;29(4):205-214. doi:10.5114/ppn.2020.103632.

Streszczenie

Can irisin become a biomarker of physical activity, or another metabolic risk assessment parameter, in psychiatric care patients?

Udostępnij

Dostępne w

Indeksowane w

Zintergrowane z

Zasady redakcyjne